Phase 1 Hematological Malignancies Clinical Trials
7 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
Hematological Malignancies
Daiichi Sankyo420 enrolled4 locationsNCT07220616
Recruiting
Phase 1
A Clinical Study of HMPL-506 in Patients With Hematological Malignancies
Hematological Malignancies
Hutchmed132 enrolled16 locationsNCT06387082
Recruiting
Phase 1
The Study of ICP-248 in Patients With Mature B-cell Malignancies
Hematological Malignancies
Beijing InnoCare Pharma Tech Co., Ltd.191 enrolled22 locationsNCT05728658
Recruiting
Phase 1
A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies
Advanced Solid TumorsHematological Malignancies
Hangzhou DAC Biotechnology Co., Ltd.110 enrolled1 locationNCT06224855
Recruiting
Phase 1Phase 2
Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide
Hematological Malignancies
Smart Immune SAS40 enrolled4 locationsNCT05768035
Recruiting
Phase 1Phase 2
Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT
Hematological Malignancies
Smart Immune SAS36 enrolled1 locationNCT04959903
Recruiting
Phase 1
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
LymphomaLeukemiaMyeloma+1 more
The Affiliated People's Hospital of Ningbo University10 enrolled1 locationNCT05528887